Shares of Viking Therapeutics fell 5.6% to $5.90 at 16:22 EST on Tuesday, after two successive sessions in a row of losses. NASDAQ Composite is dropping 1.88% to $13,633.50, after two consecutive sessions in a row of losses. This seems, up until now, an all-around rough trend exchanging session today.
Viking Therapeutics’s last close was $6.25, 71.02% under its 52-week high of $10.09.
The company’s growth estimates for the present quarter and the next is a negative 53.8% and a negative 61.5%, respectively.
Viking Therapeutics’s Stock Yearly Top and Bottom Value
Viking Therapeutics’s stock is valued at $5.90 at 16:22 EST, way under its 52-week high of $10.09 and way higher than its 52-week low of $4.55.
Viking Therapeutics’s Moving Average
Viking Therapeutics’s worth is way below its 50-day moving average of $6.71 and below its 200-day moving average of $6.51.
More news about Viking Therapeutics.